REFERENCES
R. D. Fleischmann, M. D. Adams, O. White, R. A. Clayton, E. F. Kirkness, A. R. Kerlavage, C. J. Bult, J. F. Tomb, B. A. Dougherty, J. M. Merrick, et al. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269:496–512 (1995).
D. Botstein, S. A. Chervitz, and J. M. Cherry. Yeast and model. Science 277:1259–60 (1997).
The yeast genome directory. Nature 387:5 (1997).
M. Ostergaard, H. H. Rasmussen, H. V. Nielsen, H. Vorum, T. F. Orntoft, H. Wolf, and J. E. Celis. Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res. 57:4111–7 (1997).
M. S. Boguski. The turning point in genome research. Trends Biochem. Sic. 20:295–6 (1995).
J. F. Tomb, O. White, A. R. Kerlavage, R. A. Clayton, G. G. Sutton, R. D. Fleischmann, K. A. Ketchum, H. P. Klenk, S. Gill, B. A. Dougherty, K. Nelson, J. Quackenbush, L. Zhou, E. F. Kirkness, S. Peterson, B. Loftus, D. Richardson, R. Dodson, H. G. Khalak, A. Glodek, K. McKenney, L. M. Fitzegerald, N. Lee, M. D. Adams, J. C. Venter, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:539–47 (1997).
R. F. Doolittle. A bug with excess gastric avidity. Nature 388:515–6 (1997).
W. Wierenga. Strategic alliances and the changing drug discovery process. Pharmaceut. News 3:13–16 (1996).
W. H. Moos. Combinatorial chemistry: A “Molecular diversity space” odyssey approaches 2001. Pharmaceut. News. 3:23–26 (1996).
J. C. Hogan, Jr. Directed combinatorial chemistry. Nature 384:17–9 (1996).
K. T. O'Neil, and R. H. Hoess. Phage display: protein engineering by directed evolution. Curr. Opin. Struct. Biol. 5:443–9 (1995).
G. L. Verdine. The combinatorial chemistry of nature. Nature 384:11–3 (1996).
A. F. Marsden, B. Wilkinson, J. Cortes, N. J. Dunster, J. Staunton, and P. F. Leadlay. Engineering broader specificity into an antibiotic-producing polyketide synthase. Science 279:199–202 (1998).
J. R. Broach, and J. Thorner. High-throughput screening for drug discovery. Nature 384:14–6 (1996).
N. Kinoshita, J. Minshull, and M. W. Kirschner. The identification of two novel ligands of the FGF receptor by a yeast screening method and their activity in Xenopus development. Cell 83:621–30 (1995).
B. H. Oh, J. Pandit, C. H. Kang, K. Nikaido, S. Gokcen, G. F. Ames, and S. H. Kim. Three-dimensional structures of the periplasmic lysine/arginine/ornithine-binding protein with and without a ligand. J. Biol. Chem. 268:11348–55 (1993).
P. J. O'Hara, P. O. Sheppard, H. Thogersen, D. Venezia, B. A. Haldeman, V. McGrane, K. M. Houamed, C. Thomsen, T. L. Gilbert, and E. R. Mulvihill. The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins. Neuron 11:41–52 (1993).
B. Laube, H. Hirai, M. Sturgess, H. Betz, and J. Kuhse. Molecular determinants of agonist discrimination by NMDA receptor subunits: Analysis of the glutamate binding site on the NR2B subunit. Neuron 18:493–503 (1997).
R. C. Graul, and W. Sadèe. Evolutionary relationships among proteins probed by an iterative neighborhood cluster analysis (INCA). Alignment of bacteriorhodopsins with the yeast sequence YRO2. Pharm. Res. 14:1533–41 (1997).
K. Kaupmann, K. Huggel, J. Heid, P. J. Flor, S. Bischoff, S. J. Mickel, G. McMaster, C. Angst, H. Bittiger, W. Froestl, and B. Bettler. Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. Nature 386:239–46 (1997).
I. D. Kuntz, J. M. Blaney, S. J. Oatley, R. Langridge, and T. E. Ferrin. A geometric approach to macromolecule-ligand interaction. J. Mol. Biol. 161:269–288 (1982).
N. Barkai, and S. Leibler. Robustness in simple biochemical networks. Nature 387:913–7 (1997).
Bio World Financial Watch, Bio World Publishing Group, Atlanta, GA, Volume 5,No.52.
D. J. Lockart et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nature Biotech. 14:1675–1680 (1996).
M. Schena, D. Shalon, R. W. Davis, and P. O. Brown. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270:467–70 (1995).
J. L. DeRisi, V. R. Iyer, and P. O. Brown. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278:680–6 (1997).
V. E. Velculescu, L. Zhang, B. Vogelstein, and K. W. Kinzler. Serial analysis of gene expression. Science 270:484–7 (1995).
L. Zhang, W. Zhou, V. E. Velculescu, S. E. Kern, R. H. Hruban, S. R. Hamilton, B. Vogelstein, and K. W. Kinzler. Gene expression profiles in normal and cancer cells. Science 276:1268–72 (1997).
D. Iarovici. Single blood tests might predict drug's effect on patients. J. NIH Res. 9:34–35 (1997).
C. Y. Lin, K. M. Hahnenberger, M. T. Cronin, D. Lee, N. M. Sampas, R. Kanemoto. A method for genotyping CYP2D6 and CYP2C19 using GeneChipR probe array hybridization. Poster reprint-ISSX Meeting (1996).
K.-M. Y. Covitz, G. L. Amidon, and W. Sadée. Human dipeptide transporter, hPEPT1, stably transfected into Chinese hamster ovary cells. Pharm. Res. 13:1631–1634 (1996).
D. E. Gonzales, K.-M. Y. Covitz, W. Sadée, R. J. Mrsny. An oligopeptide transporter is expressed at high levels in the pancreatic carcinoma cell lines AsPc-1 and Capan-2. Cancer Res., in press (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sadée, W. Genomics and Drugs: Finding the Optimal Drug for the Right Patient. Pharm Res 15, 959–963 (1998). https://doi.org/10.1023/A:1011949221202
Issue Date:
DOI: https://doi.org/10.1023/A:1011949221202